This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceuticalmanufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.
September 2023 saw a wave of new pharmaceuticalmanufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.
To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. Simultaneously, there is increasing need for stringent quality control and traceability throughout the supply chain to ensure patient safety.
“If we do not address the lack of a sustainable market where investments in antibiotics research and development get a fair return, by getting a proper valuation of new antibiotics, our society and our economies will suffer,” says Thomas Cueni, head of the International Federation of PharmaceuticalManufacturers and Associations.
QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. Patients should be scared. We need a 21st-century approach that puts patient safety first. The adulterated product was found to have caused nine patient deaths and 574 serious adverse events (SAEs). In other words, money over safety.
When we think of adherence in the medical world, it’s often simplified to something along the lines of the degree to which a patient correctly follows medical advice. It’s a simple statement with many, many moving parts, especially when we’re talking about patients with multiple chronic conditions. So how is this achieved?
Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.
The inventory position of 28 major pharmaceuticalmanufacturers in 2022 has been revealed in an annual report. Yet the balance sheets of the pharmaceuticalmanufacturers included in the report showed limited evidence of this. Inventories grew to a combined total of $150bn in 2022, the analysis showed.
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceuticalmanufacturing campus in Middletown, Delaware, US. The biopharmaceutical industry is part of Delaware’s DNA,” stated Delaware Governor John Carney.
Our Ludwigshafen site serves as a centre of excellence for both research and development and pharmaceuticalmanufacturing and will play a critical role in AbbVie’s future growth,” stated Azita Saleki-Gerhardt , PhD, Executive Vice President, Chief Operations Officer. The new R&D building in Germany is expected to completed in 2027.
To appreciate the scope of the challenge facing the pharmaceutical market, as well as patients across the globe, we must understand that there are two distinct threats – ‘counterfeit’ and ‘falsified’ medicines. The latest figures suggest the pharmaceutical market is worth over $1.27 Defining ‘counterfeit’ and ‘falsified’.
Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. How can we ensure that vital prescription information reaches patients when they need it? Where and how you message HCPs and patients must synchronize with when they are engaged.
Ensuring that these therapies reach the right patients at the right time requires a deep understanding of the patient journey and the healthcare professionals (HCPs) involved in their care. Lab data, coupled with strategic HCP engagement, plays a crucial role in helping pharmaceuticalmanufacturers navigate this complex landscape.
“This important investment will ensure the continuous development of our late-phase pipeline into deliveries of important medicines for treatments to patients worldwide”, Wulff declared in the original annoucement.
Fosun Pharma announced that the new facility will improve access to affordable life-saving drugs across west Africa and facilitate the transfer of medical and manufacturing knowledge to the African continent, supporting the long-term growth of the health sector in the region.
The first industrial-scale pharmaceuticalmanufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis.
Sectors such as research, testing, medical labs and pharmaceuticalmanufacturing expanded greatly during the pandemic, due to high demand for COVID-19 therapeutics. Since 2018, employment numbers in the industry have grown by 11 percent, totalling $2.9 trillion dollars in 2021.
International Federation of PharmaceuticalManufacturers and Associations (IFPMA), the global trade body for the biopharmaceutical industry , has announced its new CEO leadership team for the next two years. Who is joining IFPMA’s new CEO leadership team? The C-suite lineup includes Albert Bourla, Chairman and CEO of Pfizer.
Zygel is the first and only pharmaceuticallymanufactured, synthetic cannabidiol that is formulated as a patient-protected permeation-enhanced gel for transdermal delivery.
Patients struggle to get the necessary treatments, in some cases resulting in increased hospitalization and death. The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. drug manufacturers to continue producing generic drugs. Over 300 drugs in the U.S.
“Today marks a significant achievement for our company and reflects our continued commitment to expansion and innovation in the region,” declared Hideki Shima, Chief Manufacturing Officer, Astellas Pharma. Last year, Astellas announced plans to build the new pharmaceuticalmanufacturing facility in Tralee, where it has operated since 1990.
Moreover, pharmaceuticalmanufacturing poses a huge detriment to the state of the planet’s ecosystem. Active pharmaceutical ingredients (APIs) are particularly impact intensive, soaking up a large quantity of resources in terms of heat, energy and water when being produced.
How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5
For instance, in pharmaceuticalmanufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches. Lynne Byers, global managing director, Pharmaceuticals and Dietary Supplements Consulting, NSF.
Pharmacy's position at the intersection of the care team gives it a unique ability to connect providers, payers, and pharmaceuticalmanufacturers, and support patients to maximize their health outcomes.
The pandemic had a huge impact on the way population health decision-makers (PHDMs) navigate our industry, and now that it’s clear many of these shifts are here to stay, pharmaceuticalmanufacturers need to adjust accordingly. PHDMs know contracting alone won’t be enough to solve these challenges.
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceuticalmanufacturing site quality rating system, the Quality management maturity (QMM) programme.
This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. The price is available to cash-paying patients with a valid prescription. for only $35. Currently, an estimated 37.3 of the U.S.
The pharmaceutical industry has numerous use cases for AI. From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. It’s remarkable to see the progress made in the technology compared to only a few months ago and there are no signs of the progress slowing down.
And as these stakeholders are presented with more and more RWE from pharmaceuticalmanufacturers, they are asking tough questions to better understand whether to use this evidence when making critical decisions that impact the health of patients.
And as these stakeholders are presented with more and more RWE from pharmaceuticalmanufacturers, they are asking tough questions to better understand whether to use this evidence when making critical decisions that impact the health of patients.
The investment at the LEAP site marks the company’s biggest manufacturing investment at a single location to date. The investment will support up to 1,000 scholarships for those interested in pursuing careers in pharmaceuticalmanufacturing. Last year, the company committed to providing $42.5m
Call to Action Pharmaceuticalmanufacturers continue to push forward with active combination therapy pipelines, seeking to offer improvements over SoC in oncology. It is their prerogative to support and commercialize new innovation, providing new therapeutic options to patients. Certain markets (e.g.,
Despite physicians conducting an average of six professional searches every working day, only 17% of them searched with the words “pharmaceuticalmanufacturers.” Helpfully, Google conducted research to work out how healthcare professionals were sourcing products online.
Central Drugs Standard Control Organisation (earlier known as Drugs Controller General of India) are essential to the pharmaceutical production process. They play a crucial role in assuring the efficacy and safety of products given to patients.
The Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme is a joint initiative between the Department of Health and Social Care (DHSC), NHS England and the Association of the British Pharmaceutical Industry (ABPI). Importantly, NHS patients will be able to access new treatments earlier.
Manufacturer assistance programs are designed to make treatments more affordable, yet only about 10% of these dollars are used by patients. The cost of filling a prescription can keep 21% of patients from getting an Rx, and one in ten patients will modify their treatment plan because of cost, according to recent polling data from KFF.
By enrolling participants with a wide range of baseline characteristics, study populations will more accurately reflect the patients likely to take the drug if it is approved. Cancer patients treated in clinical trials live substantially longer than those not treated in trials and benefit from lower hospital readmissions. 2] Figure 1.
One involves helping patients, while the other requires you to meet sales quotas. You’ll find areas that are biotech hotbeds, those that have numerous pharmaceuticalmanufacturers and so on. However, is it really that easy to go from one job to another? After all, medical sales seem like a very different animal from nursing.
Additionally, it aids clients in introducing products to international markets and varied patient populations by delivering tech-driven services spanning from clinical development consultation to marketing authorisation. The company provides strategic assistance and regulatory support to biopharma firms across the lifecycle of the product.
Key study findings Study results demonstrated that precise control of tablet surface geometry “effectively tailored drug release profiles, enhancing patient compliance and treatment efficacy”. their approach in the study addresses “diverse pharmaceuticalmanufacturing demands”. Therefore, according to Wang et al.
Addition of our facility at the Princeton West Innovation Campus adds manufacturing and clinical development capabilities…to advance quality medicines faster for patients,” commented John Oyler , Co-Founder, Chairman and CEO of BeiGene. The company highlighted that its oncology pipeline addresses “80 percent of the world’s cancers”.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content